After a seven-year hiatus from football because of a life-changing injury, Shazier returns to his former team.

NervGen's groundbreaking NVG-291 treatment for spinal cord injury is currently in trials with FDA Fast Track Designation.

Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers at 13 clinics in Germany, ...

Deep brain stimulation of the lateral hypothalamus improves walking and promotes recovery in patients with spinal cord injury ...

Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers have investigated this with promising results. For the first time, it was possible to identify patient ...

Spinal cord injuries are among the most serious medical conditions, often leading to life-altering physical, emotional, and ...

Shares in the company were up 7% at market open following the first approval for a non-invasive spinal cord stimulator for ...

The spinal cord stimulation technology from Swiss company Onward, called ARC-E-X, helps paralyzed people regain some mobility ...

A Phase I clinical trial led by researchers at University of California San Diego School of Medicine has demonstrated the ...

The FDA Thursday approved the ARC-EX System designed to restore mobility after spinal cord injury by delivering programmed ...

A phase 1 clinical trial demonstrated the long-term safety and feasibility of neural stem cell transplantation for treating ...

Pressure ulcers (PUs) acquired during initial hospitalization for spinal cord injury (SCI) are associated with poor long-term ...